51 related articles for article (PubMed ID: 27643573)
41. Evolving treatment strategies in patients with high-risk acute myeloid leukemia.
Schiller GJ
Leuk Lymphoma; 2014 Nov; 55(11):2438-48. PubMed ID: 24432896
[TBL] [Abstract][Full Text] [Related]
42. Acute myeloid leukaemia: optimising treatment in elderly patients.
Jackson GH; Taylor PR
Drugs Aging; 2002; 19(8):571-81. PubMed ID: 12207551
[TBL] [Abstract][Full Text] [Related]
43. Response Kinetics and Clinical Benefits of Nonintensive AML Therapies in the Absence of Morphologic Response.
Stein EM; DiNardo CD; Pollyea DA; Schuh AC
Clin Lymphoma Myeloma Leuk; 2020 Feb; 20(2):e66-e75. PubMed ID: 31862181
[TBL] [Abstract][Full Text] [Related]
44. Impact of age, functional status, and comorbidities on quality of life and outcomes in elderly patients with AML: review.
Laribi K; Sobh M; Ghez D; Baugier de Materre A
Ann Hematol; 2021 Jun; 100(6):1359-1376. PubMed ID: 33796898
[TBL] [Abstract][Full Text] [Related]
45. Consolidation Therapy for Acute Myeloid Leukemia: Defining a Benchmark.
Luger SM
J Clin Oncol; 2021 Mar; 39(8):870-875. PubMed ID: 33411591
[No Abstract] [Full Text] [Related]
46. Consolidation in AML: Abundant opinion and much unknown.
Weigert N; Rowe JM; Lazarus HM; Salman MY
Blood Rev; 2022 Jan; 51():100873. PubMed ID: 34483002
[TBL] [Abstract][Full Text] [Related]
47. Karyotype plus NPM1 mutation status defines a group of elderly patients with AML (≥60 years) who benefit from intensive post-induction consolidation therapy.
Sperr WR; Zach O; Pöll I; Herndlhofer S; Knoebl P; Weltermann A; Streubel B; Jaeger U; Kundi M; Valent P
Am J Hematol; 2016 Dec; 91(12):1239-1245. PubMed ID: 27643573
[TBL] [Abstract][Full Text] [Related]
48. Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
Ferrara F
Hematol Oncol; 2014 Mar; 32(1):1-9. PubMed ID: 23512815
[TBL] [Abstract][Full Text] [Related]
49. Acute myeloid leukemia: 2013 update on risk-stratification and management.
Estey EH
Am J Hematol; 2013 Apr; 88(4):318-27. PubMed ID: 23526416
[TBL] [Abstract][Full Text] [Related]
50. Is there justification for 4 cycles of consolidation therapy in AML?
Schlenk RF
Best Pract Res Clin Haematol; 2016 Dec; 29(4):341-344. PubMed ID: 27890257
[TBL] [Abstract][Full Text] [Related]
51. Prognostic Significance of Complex Karyotypes in Acute Myeloid Leukemia.
Daneshbod Y; Kohan L; Taghadosi V; Weinberg OK; Arber DA
Curr Treat Options Oncol; 2019 Feb; 20(2):15. PubMed ID: 30741367
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
